Atorvastatin Calcium Tablets — Class III drug recall D-0888-2018
Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2018-06-27, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0888-2018 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States |
| Recall initiated | 2018-06-12 |
| Classified | 2018-06-21 |
| Reported by FDA | 2018-06-27 |
| Terminated | 2019-11-08 |
| Distributed | Nationwide (US) |
| Quantity | 130,081 bottles |
| Reason classes | specification failure |
| NDC | 55111-0121, 55111-0121-05, 55111-0121-10, 55111-0121-30, 55111-0121-60, 55111-0121-90, 55111-0122, 55111-0122-05, 55111-0122-10, 55111-0122-30, 55111-0122-60, 55111-0122-90, 55111-0123, 55111-0123-05, 55111-0123-10, 55111-0123-30, 55111-0123-60, 55111-0123-90 |
Product
Atorvastatin Calcium Tablets, 40 mg*, packaged as a) 90-count bottle (NDC 55111-123-90 and b) 500-count bottle (NDC 55111-123-05), Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0888-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.